Management of patients with hypertension, coronary heart disease and chronic heart failure during the COVID-19 pandemic in the primary care setting-Reference-Cited by-同舟云学术

Management of patients with hypertension, coronary heart disease and chronic heart failure during the COVID-19 pandemic in the primary care setting

Published:2022-08-25 Issue:4 Volume:28 Page:464-476
ISSN:2411-8524
Container-title:"Arterial’naya Gipertenziya" ("Arterial Hypertension")
language:
Short-container-title:Arter. gipertenz.

Author:

Konradi A. O.¹^ORCID,Drapkina O. M.²^ORCID,Nedogoda S. V.³^ORCID,Arutyunov G. P.⁴^ORCID,Karpov Yu. A.⁵^ORCID,Kobalava Zh. D.⁶^ORCID,Orlova Ya. A.⁷^ORCID,Sychev D. A.⁸^ORCID,Zyryanov S. K.⁹^ORCID

Affiliation:

1. Almazov National Medical Research Center

2. National Medical Research Center for Therapy and Preventive Medicine

3. Volgograd State Medical University

4. Pirogov Russian National Research Medical University

5. Institute of Clinical Cardiology named after A.L. Myasnikov of the Research Center of Cardiology

6. Peoples' Friendship University of Russia

7. Medical Scientific and Educational Center of the Lomonosov Moscow State University

8. Russian Medical Academy of Continuing Professional Education

9. City Clinical Hospital No. 24

Abstract

On December 1, 2021, a meeting of the Council of experts on the treatment of hypertension, coronary heart disease, and chronic heart failure during the COVID-19 pandemic was held remotely to adjust and adapt current approaches to outpatient treatment of the above pathologies under the current epidemiological situation. The meeting was attended by leading Russian specialists from federal medical research centers of cardiology and therapy.

Publisher

Arterialnaya Gipertenziya

Subject

Cardiology and Cardiovascular Medicine,Internal Medicine

Reference55 articles.

1. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382(8):727-733. doi:10.1056/NEJMoa2001017

2. Task Force for the management of COVID-19 of the European Society of Cardiology. European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1 — epidemiology, pathophysiology, and diagnosis. Eur Heart J. 2021;43(11):1033-1058. doi:10.1093/eurheartj/ehab696

3. Figliozzi S, Masci PG, Navid Ahmadi N, Tondi L, Koutli E, Aimo A et al. Predictors of adverse prognosis in COVID-19: a systematic review and meta-analysis. Eur J Clin Invest. 2020;50(10): e13362. doi:10.1111/eci.13362

4. Ssentongo P, Ssentongo AE, Heilbrunn ES, Ba DM, Chinchilli VM. Association of cardiovascular disease and 10 other pre-existing comorbidities with COVID-19 mortality: a systematic review and meta-analysis. PLoS One. 2020;15(8):e0238215. doi:10.1371/journal.pone.0238215

5. Barron E, Bakhai C, Kar P, Weaver A, Bradley D, Ismail H et al. Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study. Lancet Diabetes Endocrinol. 2020;8(10):813-822. doi:10.1016/S22138587(20)30272-2

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Associations of arterial hypertension and the severity of the course of a new coronavirus infection;Ateroscleroz;2023-04-04